UBS analyst Kavya Deshpande maintained a Buy rating on bioMerieux (0RUG – Research Report) today and set a price target of €138.00. The ...

Jonathan Golub, chief US equity strategist at UBS Securities LLC, and Patrick Palfrey, UBS’s senior equity strategist and ...

In a report released yesterday, Owen Birrell from RBC Capital maintained a Hold rating on Sims (SMUPF – Research Report), with a price target ...

RBC Capital Markets came in at No. 5 on Dealogic’s 2024 ... alongside Goldman Sachs and UBS.

The Goodman raising, the ASX’s sixth-largest ever and the bourse’s largest real estate deal, was done unsounded and with no ...

Anke Reingen, RBC: Questioned U.S. wealth management ... Jeremy Sigee, BNP Paribas: Inquired about capital markets revenue and UBS Americas CET1 ratio reductions. Tuckner highlighted the timing ...

Investing.com -- UBS on Tuesday posted a stronger-than ... but this could be due to seasonality,” said analysts at RBC Capital Markets in a note. Net interest income in GWM rose 4% from the ...

Mexican fast-food chain Guzman y Gomez on Friday reported first-half underlying earnings that missed estimates as declining ...

Meanwhile, UBS, RBC Capital Markets, and Truist Securities have raised their price targets for ProLogis to $137, $128, and $123, respectively, maintaining their Buy ratings. ProLogis has reported ...

Meanwhile, UBS, RBC Capital Markets, and Truist Securities have raised their price targets for ProLogis to $137, $128, and $123, respectively, maintaining their Buy ratings. ProLogis has reported a 17 ...

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...